Enzymedica
Latest round
- Series A
Last raised
- Nov 2013
Total raised
- $23M
Investors
- 1
About Enzymedica
Enzymedica, Inc.Founded in 1998 and headquartered in Venice, US, Enzymedica focuses on providing enzyme-based digestive health supplements.Enzymedica® specializes in digestive health supplements, which include products such as Digest Gold®, Digest Complete®, and Lypo Gold™. These enzyme-based products are formulated to address specific digestive issues like gas, bloating, and food intolerance, using high-quality, scientifically validated ingredients.Enzymedica® generates revenue through direct-to-consumer sales and partnerships with retailers. Their sales model includes one-time purchases and subscription options, enhancing customer loyalty. The company is developing new products aimed at addressing a broader range of digestive health needs, with anticipated launches by the end of 2024. Additionally, Enzymedica is targeting expansion into European and Asian markets to enhance its global reach.
Who invested in Enzymedica
1 investor across 1 round
See all investors in Enzymedica
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 15, 2013
Amount
$23M
Investors
Questions about Enzymedica
Who invested in Enzymedica?
Enzymedica has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Enzymedica raised?
Enzymedica has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Enzymedica last raise money?
Enzymedica's most recent round on record is a Series A, in Nov 2013.
What does Enzymedica do?
Enzymedica is a biopolymers company.
Where is Enzymedica headquartered?
Enzymedica is headquartered in Venice, US.
Which VCs invest in companies like Enzymedica?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biopolymers companies at Enzymedica's stage. Their profiles are linked below.
VCs backing biopolymers startups at Series A
Raising like Enzymedica? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.